A worldwide clinical trial has been structured to assess the effects of pemvidutide on enhancing fibrosis, resolving MASH, and improving overall clinical outcomes. This study will involve a significant number of participants from different regions, with the aim of obtaining comprehensive data on the potential benefits of this treatment.